| abstract |
The invention provides a method of treating cancer or delaying its progression in an individual, comprising administering to the subject an anti-human OX40 agonist antibody. In some embodiments, the antibody is administered in an amount of about 0.2 mg, about 0.8 mg, about 3.2 mg, about 12 mg, about 40 mg, about 80 mg, about 130 mg, about 160 mg, about 300 mg, about 320 mg, about 400 mg, ≪ / RTI > |